Effect of flunarizine on the human red cell shape changes and calcium deposition induced by A 23187.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D000001:Calcimycin / Q000494:pharmacology*; D002118:Calcium / Q000378:metabolism*; D002746:Chlorpromazine / Q000494:pharmacology; D002936:Cinnarizine / Q000031:analogs & derivatives / Q000494:pharmacology*; D004176:Dipyridamole / Q000494:pharmacology; D004910:Erythrocyte Membrane / Q000187:drug effects; D004913:Erythrocytes, Abnormal / Q000187:drug effects* / Q000648:ultrastructure; D005444:Flunarizine; D006801:Humans; D006863:Hydrogen-Ion Concentration; D010879:Piperazines / Q000494:pharmacology*; D013468:Suloctidil / Q000494:pharmacology; D013997:Time Factors
D000900:Anti-Bacterial Agents; D010879:Piperazines; D000001:Calcimycin; D002936:Cinnarizine; D004176:Dipyridamole; D005444:Flunarizine; D002118:Calcium; D002746:Chlorpromazine; D013468:Suloctidil